Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study.
about
Peptide receptor targeting in cancer: the somatostatin paradigm.New agonist- and antagonist-based treatment approaches for advanced prostate cancer.Nonmetastatic castration-resistant prostate cancer.Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management.Investigational serine/threonine kinase inhibitors against prostate cancer metastases.Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients.
P2860
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of the somatostatin ana ...... : results of a phase II study.
@ast
Effect of the somatostatin ana ...... : results of a phase II study.
@en
type
label
Effect of the somatostatin ana ...... : results of a phase II study.
@ast
Effect of the somatostatin ana ...... : results of a phase II study.
@en
prefLabel
Effect of the somatostatin ana ...... : results of a phase II study.
@ast
Effect of the somatostatin ana ...... : results of a phase II study.
@en
P2093
P1433
P1476
Effect of the somatostatin ana ...... : results of a phase II study.
@en
P2093
Andrea L Harzstark
Charles J Ryan
Eric J Small
Jeremy Sharib
Lawrence Fong
Terence W Friedlander
Vivian K Weinberg
P304
P356
10.1016/J.UROLONC.2010.06.014
P577
2010-10-02T00:00:00Z